3M and MIT Working on Rapid COVID-19 Diagnostic Test
Industrial giant 3M (NYSE: MMM) is working with researchers from MIT to develop a rapid-response COVID-19 test. The test was selected by the National Institutes of Health (NIH) to be included in a program to accelerate COVID-19 diagnostic initiatives.
The collaborators aim to provide a test that delivers highly accurate results within minutes, and that can be mass-produced. It will detect virus antigens via a paper-based device, and the results will be available at the point of testing.
The effort taps into 3M's expertise in medical device manufacturing, as well as its institutional experience in biomaterials and bioprocessing. It uses its biomaterials technology in the production of air filtration products, as well as in pathogen detection products used for food safety and testing.
Source Fool.com
